Pharmacotherapy challenges in patients with first-episode psychosis

Journal of Affective Disorders

Volumn 138, Issue SUPPL., 2012, Pages

  Abdel Baki, Amal ^a   Ouellet Plamondon, Clairélaine ^a   Malla, Ashok ^b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

Adolescent; First episode psychosis; Non adherence; Pharmacotherapy; Schizophrenia

Indexed keywords

AMISULPRIDE; BENZODIAZEPINE; CLOZAPINE; DIPHENHYDRAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PROLACTIN; PROPRANOLOL; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

AGRANULOCYTOSIS; AKATHISIA; ARTICLE; ATTITUDE TO ILLNESS; BLOOD TOXICITY; BRADYKINESIA; CANNABIS ADDICTION; CARDIOVASCULAR SYSTEM; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG WITHDRAWAL; DYSPHORIA; DYSTONIA; EXTRAPYRAMIDAL SYNDROME; FAMILY RELATION; FIRST EPISODE PSYCHOSIS; HEALTH BELIEF; HUMAN; HYPERPROLACTINEMIA; LOW DRUG DOSE; METABOLIC SYNDROME X; MUSCLE RIGIDITY; NEUTROPENIA; ORTHOSTATIC HYPOTENSION; PARKINSONISM; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RECURRENT DISEASE; SEDATION; SIDE EFFECT; SOCIAL SUPPORT; SUBSTANCE ABUSE; TACHYCARDIA; TREATMENT PLANNING; TREMOR; WEIGHT GAIN;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; ATTITUDE TO HEALTH; EARLY MEDICAL INTERVENTION; HUMANS; PATIENT COMPLIANCE; PSYCHOTIC DISORDERS; RECURRENCE; RISK FACTORS; SOCIAL SUPPORT; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84858705903     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2012.02.029     Document Type: Article

References (150)

1. A. Abdel-Baki, A. Lesage, L. Nicole, M. Cossette, E. Salvat, and P. Lalonde Schizophrenia, an illness with bad outcome Canadian Journal of Psychiatry 456 2011 92 101
2. J. Addington, E.L. Coldham, B. Jones, T. Ko, and D. Addington The first episode of psychosis: the experience of relatives Acta Psychiatrica Scandinavica 108 2003 285 289 (Pubitemid 37175903)
3. J. Addington, E. Leriger, and D. Addington Symptom outcome 1 year after admission to an early psychosis program Canadian Journal of Psychiatry 48 2003 204 207 (Pubitemid 36596949)
4. C.L. Alfaro, M. Wudarsky, R. Nicolson, P. Gochman, A. Sporn, M. Lenane, and J.L. Rapoport Correlation of antipsychotic and prolactin concentrations in children and adolescents acutely treated with haloperidol, clozapine, or olanzapine Journal of Child and Adolescent Psychopharmacology 12 2002 83 91 (Pubitemid 34779022)
5. D.B. Allison, and D.E. Casey Antipsychotic-induced weight gain: a review of the literature The Journal of Clinical Psychiatry 62 Suppl. 7 2001 22 31 (Pubitemid 32402182)
6. M. Álvarez-Jiménez, J.F. Gleeson, S. Cotton, D. Wade, D. Gee, T. Pearce, K. Crisp, D. Spiliotacopoulos, B. Newman, and P.D. McGorry Predictors of adherence to cognitive-behavioural therapy in first-episode psychosis Canadian Journal of Psychiatry 54 2009 710 718
7. J.M. Alvir, and J.A. Lieberman Agranulocytosis: incidence and risk factors The Journal of Clinical Psychiatry 55 Suppl. B 1994 137 138 (Pubitemid 24353038)
8. K.K. Anderson, R. Fuhrer, and A.K. Malla The pathways to mental health care of first-episode psychosis patients: a systematic review Psychological Medicine 40 2010 1585 1597
9. C. Asenjo Lobos, K. Komossa, C. Rummel-Kluge, H. Hunger, F. Schmid, S. Schwarz, and S. Leucht Clozapine versus other atypical antipsychotics for schizophrenia Cochrane Database of Systematic Reviews 11 2010 CD006633
10. A.G. Awad, and L.N. Voruganti New antipsychotics, compliance, quality of life, and subjective tolerability - are patients better off? Canadian Journal of Psychiatry 49 2004 297 302 (Pubitemid 38724634)
11. A.G. Awad, and L.N. Voruganti Neuroleptic dysphoria: revisiting the concept 50 years later Acta Psychiatrica Scandinavica. Supplementum 427 2005 6 13 (Pubitemid 40780194)
12. T. Ballageer, A. Malla, R. Manchanda, J. Takhar, and R. Haricharan Is adolescent-onset first-episode psychosis different from adult onset? Journal of the American Academy of Child and Adolescent Psychiatry 44 2005 782 789 (Pubitemid 41026282)
13. V. Baloush-Kleinman, S.Z. Levine, D. Roe, D. Shnitt, A. Weizman, and M. Poyurovsky Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study Schizophrenia Research 130 2011 176 181
14. M. Birchwood, P. Todd, and C. Jackson Early intervention in psychosis: the critical period hypothesis The British Journal of Psychiatry. Supplement 172 1998 53 59 (Pubitemid 28258899)
15. W. Buis Patients' opinions concerning side effects of depot neuroleptics The American Journal of Psychiatry 149 1992 844 845
16. M.J. Byerly, R. Fisher, T. Carmody, and A.J. Rush A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder The Journal of Clinical Psychiatry 66 2005 997 1001 (Pubitemid 41191791)
17. C.M. Cassidy, R. Norman, R. Manchanda, N. Schmitz, and A. Malla Testing definitions of symptom remission in first-episode psychosis for prediction of functional outcome at 2 years Schizophrenia Bulletin 36 2010 1001 1008
18. S. Chabroux, E. Haffen, and A. Penfornis Diabetes and second-generation (atypical) antipsychotics Annales d'endocrinologie 70 2009 202 210
19. A. Charach, T. Volpe, K.M. Boydell, and R.E. Gearing A theoretical approach to medication adherence for children and youth with psychiatric disorders Harvard Review of Psychiatry 16 2008 126 135 (Pubitemid 351549822)
20. E.L. Coldham, J. Addington, and D. Addington Medication adherence of individuals with a first episode of psychosis Acta Psychiatrica Scandinavica 106 2002 286 290
21. C.U. Correll Monitoring and management of antipsychotic-related metabolic and endocrine adverse events in pediatric patients International Review of Psychiatry 20 2008 195 201 (Pubitemid 351489515)
22. C.U. Correll, and H.E. Carlson Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents Journal of the American Academy of Child and Adolescent Psychiatry 45 2006 771 791 (Pubitemid 43932904)
23. C.U. Correll, J.B. Penzner, U.H. Parikh, T. Mughal, T. Javed, M. Carbon, and A.K. Malhotra Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents Child and Adolescent Psychiatric Clinics of North America 15 2006 177 206 (Pubitemid 41735243)
24. A.M. Costa, M.S. Lima, and J. Mari Jde A systematic review on clinical management of antipsychotic-induced sexual dysfunction in schizophrenia São Paulo Medical Journal 124 2006 291 297 (Pubitemid 46210378)
25. N. Crumlish, P. Whitty, M. Clarke, S. Browne, M. Kamali, M. Gervin, O. McTigue, A. Kinsella, J.L. Waddington, C. Larkin, and E. O'Callaghan Beyond the critical period: longitudinal study of 8-year outcome in first-episode non-affective psychosis The British Journal of Psychiatry 194 2009 18 24
26. J.C. Day, R.P. Bentall, C. Roberts, F. Randall, A. Rogers, D. Cattell, D. Healy, P. Rae, and C. Power Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals Archives of General Psychiatry 62 2005 717 724 (Pubitemid 41002752)
27. W.S. Fenton, C.R. Blyler, and R.K. Heinssen Determinants of medication compliance in schizophrenia: empirical and clinical findings Schizophrenia Bulletin 23 1997 637 651 (Pubitemid 27485972)
28. R.L. Findling, A. Robb, M. Nyilas, R.A. Forbes, N. Jin, S. Ivanova, R. Marcus, R.D. McQuade, T. Iwamoto, and W.H. Carson A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia The American Journal of Psychiatry 165 11 2008 1432 1441
29. D. Fraguas, J. Merchán-Naranjo, P. Laita, M. Parellada, D. Moreno, A. Ruiz-Sancho, A. Cifuentes, M. Giráldez, and C. Arango Metabolic and hormonal side effects in children and adolescents treated with second-generation antipsychotics The Journal of Clinical Psychiatry 69 2008 1166 1175 (Pubitemid 352031601)
30. D. Fraguas, C.U. Correll, J. Merchán-Naranjo, M. Rapado-Castro, M. Parellada, C. Moreno, and C. Arango Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons European Neuropsychopharmacology 21 2010 621 645
31. A.F. Frank, and J.G. Gunderson The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome Archives of General Psychiatry 47 1990 228 236 (Pubitemid 20086675)
32. L. Franz, T. Carter, A.S. Leiner, E. Bergner, N.J. Thompson, and M.T. Compton Stigma and treatment delay in first-episode psychosis: a grounded theory study Early Intervention in Psychiatry 4 2010 47 56
33. W. Gaebel, M. Jänner, N. Frommann, A. Pietzcker, W. Köpcke, M. Linden, P. Müller, F. Müller-Spahn, and J. Tegeler First vs multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies Schizophrenia Research 53 2002 145 159 (Pubitemid 33139783)
34. I. Gasquet, P. Flandre, N. Heurtebize, C. Deal, E. Perrin, F. Chartier, and A. Fourrier-Réglat Pattern and evolution of the prescription of olanzapine during one year: results of the cohort study ECOL Encephale 35 2009 25 31
35. R.E. Gearing, I. Mian, A. Sholonsky, J. Barber, D. Nicholas, R. Lewis, L. Solomon, C. Williams, S. Lightbody, M. Steele, B. Davidson, R. Manchanda, L. Joseph, K. Handelman, and A. Ickowicz Developing a risk-model of time to first-relapse for children and adolescents with a psychotic disorder The Journal of Nervous and Mental Disease 197 2009 6 14
36. J.F. Gleeson, M. Alvarez-Jimenez, S.M. Cotton, A.G. Parker, and S. Hetrick A systematic review of relapse measurement in randomized controlled trials of relapse prevention in first-episode psychosis Schizophrenia Research 119 2010 79 88
37. N.H. Golden, and J.L. Carlson The pathophysiology of amenorrhea in the adolescent Annals of the New York Academy of Sciences 1135 2008 163 178 (Pubitemid 351862129)
38. P.M. Haddad, and A. Wieck Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management Drugs 64 2004 2291 2314 (Pubitemid 39388605)
39. G. Harrison, K. Hopper, T. Craig, E. Laska, C. Siegel, J. Wanderling, K.C. Dube, K. Ganev, R. Giel, W. an der Heiden, S.K. Holmberg, A. Janca, P.W. Lee, C.A. León, S. Malhotra, A.J. Marsella, Y. Nakane, N. Sartorius, Y. Shen, C. Skoda, R. Thara, S.J. Tsirkin, V.K. Varma, D. Walsh, and D. Wiersma Recovery from psychotic illness: a 15- and 25-year international follow-up study The British Journal of Psychiatry 178 2001 506 517 (Pubitemid 32531743)
40. P.O. Harvey, M. Lepage, and A. Malla Benefits of enriched intervention compared with standard care for patients with recent-onset psychosis: a meta-analytic approach Canadian Journal of Psychiatry 52 2007 464 472 (Pubitemid 47195852)
41. M.I. Herz, J.S. Lamberti, J. Mintz, R. Scott, S.P. O'Dell, L. McCartan, and G. Nix A program for relapse prevention in schizophrenia: a controlled study Archives of general psychiatry 57 2000 277 283 (Pubitemid 30140437)
42. M. Hill, N. Crumlish, P. Whitty, M. Clarke, S. Browne, M. Kamali, A. Kinsella, J.L. Waddington, C. Larkin, and E. O'Callaghan Nonadherence to medication four years after a first episode of psychosis and associated risk factors Psychiatric Services 61 2010 189 192
43. C.G. Huber, D. Naber, and M. Lambert Incomplete remission and treatment resistance in first-episode psychosis: definition, prevalence and predictors Expert Opinion on Pharmacotherapy 9 2008 2027 2038
44. R. Ilott Does compliance therapy improve use of antipsychotic medication? British Journal of Community Nursing 10 2005 514 519
45. International Early Psychosis Association Writing Group International clinical practice guidelines for early psychosis The British Journal of Psychiatry 48 2005 s120 s124 (Suppl.)
46. S.N. Iyer, H. Loohuis, N. Pawliuk, R. Joober, and A.K. Malla Concerns reported by family members of individuals with first-episode psychosis Early Intervention in Psychiatry 5 2011 163 167
47. C. Jackson, C. Knott, A. Skeate, and M. Birchwood The trauma of first episode psychosis: the role of cognitive mediation The Australian and New Zealand Journal of Psychiatry 38 2004 327 333 (Pubitemid 38765233)
48. P.B. Jones, T.R. Barnes, L. Davies, G. Dunn, H. Lloyd, K.P. Hayhurst, R.M. Murray, A. Markwick, and S.W. Lewis Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1) Archives of General Psychiatry 63 2006 1079 1087 (Pubitemid 44498387)
49. R.S. Kahn, W.W. Fleischhacker, H. Boter, M. Davidson, Y. Vergouwe, I.P. Keet, M.D. Gheorghe, J.K. Rybakowski, S. Galderisi, J. Libiger, M. Hummer, S. Dollfus, J.J. López-Ibor, L.G. Hranov, W. Gaebel, J. Peuskens, N. Lindefors, A. Riecher-Rössler, D.E. Grobbee EUFEST study group Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial Lancet 371 2008 1085 1097 (Pubitemid 351418005)
50. M. Kamali, B.D. Kelly, M. Clarke, S. Browne, M. Gervin, A. Kinsella, A. Lane, C. Larkin, and E. O'Callaghan A prospective evaluation of adherence to medication in first episode schizophrenia European Psychiatry 21 2006 29 33 (Pubitemid 43243050)
51. O. Kampman, P. Laippala, J. Väänänen, E. Koivisto, P. Kiviniemi, N. Kilkku, and K. Lehtinen Indicators of medication compliance in first-episode psychosis Psychiatric Research 110 2002 39 48 (Pubitemid 34451095)
52. J.M. Kane Treatment strategies to prevent relapse and encourage remission The Journal of Clinical Psychiatry 68 Suppl. 14 2007 27 30
53. J.M. Kane Addressing side effects from antipsychotic treatment in schizophrenia The Journal of Clinical Psychiatry 72 2011 e07
54. S. Kapur, R. Zipursky, C. Jones, G. Remington, and S. Houle Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia The American Journal of Psychiatry 157 4 2000 514 520 (Pubitemid 30191189)
55. S. Kapur, O. Agid, R. Mizrahi, and M. Li How antipsychotics work: from receptors to reality NeuroRx 3 2006 10 21 (Pubitemid 43276632)
56. R. Kemp, P. Hayward, G. Applewhaite, B. Everitt, and A. David Compliance therapy in psychotic patients: randomised controlled trial BMJ 312 1996 345 349 (Pubitemid 26050038)
57. R. Kemp, G. Kirov, B. Everitt, P. Hayward, and A. David Randomised controlled trial of compliance therapy. 18-month follow-up The British Journal of Psychiatry 172 1998 413 419 (Pubitemid 28204550)
58. N. Kilkku, T. Munnukka, and K. Lehtinen From information to knowledge: the meaning of information-giving to patients who had experienced first-episode psychosis Journal of Psychiatric and Mental Health Nursing 10 2003 57 64 (Pubitemid 37264961)
59. J.H. Kim, and H.J. Byun Non-motor cognitive-perceptual dysfunction associated with drug-induced parkinsonism Human Psychopharmacology 24 2009 129 133
60. J. Kreyenbuhl, R.W. Buchanan, F.B. Dickerson, L.B. Dixon Schizophrenia Patient Outcomes Research Team (PORT) The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009 Schizophrenia Bulletin 36 2010 94 103
61. S. Kumra, J.V. Oberstar, L. Sikich, R.L. Findling, J.M. McClellan, S. Vinogradov, and S. Charles Schulz Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia Schizophrenia Bulletin 34 2008 60 71 (Pubitemid 350262286)
62. J.S. Kwon, J.H. Jang, D.H. Kang, S.Y. Yoo, Y.K. Kim, S.J. Cho APLUS study group Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study Psychiatry and Clinical Neurosciences 63 2009 73 81
63. M.J. Labellarte, J.E. Crosson, and M.A. Riddle The relevance of prolonged QTc measurement to pediatric psychopharmacology Journal of the American Academy of Child and Adolescent Psychiatry 42 2003 642 650 (Pubitemid 39625049)
64. J.P. Lacro, L.B. Dunn, C.R. Dolder, S.G. Leckband, and D.V. Jeste Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature The Journal of Clinical Psychiatry 63 2002 892 909 (Pubitemid 35231730)
65. M. Lambert, D. Naber, and C.G. Huber Management of incomplete remission and treatment resistance in first-episode psychosis Expert Opinion on Pharmacotherapy 9 2008 2039 2051
66. T.K. Larsen, I. Joa, J. Langeveld, and J.O. Johannessen Optimizing health-care systems to promote early detection of psychosis Early Intervention in Psychiatry 3 Suppl. 1 2009 S13 S16
67. M. Lepage, L. Buchy, M. Bodnar, M.C. Bertrand, R. Joober, and A. Malla Cognitive insight and verbal memory in first episode of psychosis European Psychiatry 23 2008 368 374
68. M. Lepage, M. Bodnar, L. Buchy, R. Joober, and A. Malla Early medication adherence and insight change in first-episode psychosis Clinical Schizophrenia & Related Psychoses 3 2010 201 208
69. H. Lester, M. Marshall, P. Jones, D. Fowler, T. Amos, N. Khan, and M. Birchwood Views of young people in early intervention services for first-episode psychosis in England Psychiatric Services 62 2011 882 887
70. S. Leucht, C. Corves, D. Arbter, R.R. Engel, C. Li, and J.M. Davis Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis Lancet 373 2009 31 41
71. J.A. Lieberman, M. Phillips, H. Gu, S. Stroup, P. Zhang, L. Kong, Z. Ji, G. Koch, and R.M. Hamer Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine Neuropsychopharmacology 28 2003 995 1003
72. M. Linden, F. Godemann, W. Gaebel, W. Köpke, P. Müller, F. Müller-Spahn, A. Pietzcker, and J. Tegeler A prospective study of factors influencing adherence to a continuous neuroleptic treatment program in schizophrenia patients during 2 years Schizophrenia Bulletin 27 2001 585 596 (Pubitemid 34093245)
73. L.R. Lopez Adolescents' attitudes toward mental illness and perceived sources of their attitudes: an examination of pilot data Archives of Psychiatric Nursing 5 1991 271 280
74. A.K. Malla, R.M. Norman, R. Manchanda, and L. Townsend Symptoms, cognition, treatment adherence and functional outcome in first-episode psychosis Psychological Medicine 32 2002 1109 1119
75. A. Malla, R. Norman, N. Schmitz, R. Manchanda, L. Béchard-Evans, J. Takhar, and R. Haricharan Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study Psychological Medicine 36 2006 649 658
76. A. Malla, S. Lal, N.C. Vracotas, K. Goldberg, and R. Joober Early intervention in psychosis: specialized intervention and early case identification Encephale 36 Suppl. 3 2010 S38 S45
77. S.R. Marder Subjective experiences on antipsychotic medications: synthesis and conclusions Acta Psychiatrica Scandinavica. Supplementum 427 2005 43 46 (Pubitemid 40780199)
78. S.R. Marder, S.M. Essock, A.L. Miller, R.W. Buchanan, D.E. Casey, J.M. Davis, J.M. Kane, J.A. Lieberman, N.R. Schooler, N. Covell, S. Stroup, E.M. Weissman, D.A. Wirshing, C.S. Hall, L. Pogach, X. Pi-Sunyer, J.T. Bigger Jr., A. Friedman, D. Kleinberg, S.J. Yevich, B. Davis, and S. Shon Physical health monitoring of patients with schizophrenia The American Journal of Psychiatry 161 2004 1334 1349 (Pubitemid 38989085)
79. M. Marshall, and J. Rathbone Early intervention for psychosis Cochrane Database of Systematic Reviews 6 2011 CD004718
80. M. Marshall, S. Lewis, A. Lockwood, R. Drake, P. Jones, and T. Croudace Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review Archives of General Psychiatry 62 2005 975 983 (Pubitemid 41248376)
81. G. Masi, and F. Liboni Management of schizophrenia in children and adolescents: focus on pharmacotherapy Drugs 71 2011 179 208
82. G. Masi, A. Cosenza, M. Mucci, and P. Brovedani A 3-year naturalistic study of 53 preschool children with pervasive developmental disorders treated with risperidone The Journal of Clinical Psychiatry 64 2003 1039 1047 (Pubitemid 37158249)
83. T.V. McCann, D.I. Lubman, and E. Clark Responding to stigma: first-time caregivers of young people with first-episodepsychosis Psychiatric Services 62 2011 548 550
84. J.P. McEvoy, J. Johnson, D. Perkins, J.A. Lieberman, R.M. Hamer, R.S. Keefe, M. Tohen, I.D. Glick, and T. Sharma Insight in first-episode psychosis Psychological Medicine 36 2006 1385 1393 (Pubitemid 44355974)
85. J.P. McEvoy, D. Zigman, and H.C. Margolese First- and second-generation antipsychotics Canadian Journal of Psychiatry 55 2010 144 148 (discussion 148-149)
86. W.R. McFarlane, E. Lukens, B. Link, R. Dushay, S.A. Deakins, M. Newmark, E.J. Dunne, B. Horen, and J. Toran Multiple-family groups and psychoeducation in the treatment of schizophrenia Archives of General Psychiatry 52 1995 679 687
87. P.D. McGorry The concept of recovery and secondary prevention in psychotic disorders The Australian and New Zealand Journal of Psychiatry 26 1992 3 17
88. P.D. McGorry, E. Killackey, and A. Yung Early intervention in psychosis: concepts, evidence and future directions World Psychiatry 7 2008 148 156
89. A.M. McIntosh, L. Conlon, S.M. Lawrie, and A.C. Stanfield Compliance therapy for schizophrenia Cochrane Database of Systematic Reviews 3 2006 CD003442
90. C. Mehler-Wex, M. Kölch, J. Kirchheiner, G. Antony, J.M. Fegert, and M. Gerlach Drug monitoring in child and adolescent psychiatry for improved efficacy and safety of psychopharmacotherapy Child and Adolescent Psychiatric and Mental Health 3 2009 14
91. D.D. Miller Review and management of clozapine side effects The Journal of Clinical Psychiatry 61 Suppl. 8 2000 14 17 (discussion 18-19)
92. D. Misdrahi, H. Verdoux, C. Lançon, and F. Bayle The 4-point ordinal alliance self-report: a self-report questionnaire for assessing therapeutic relationships in routine mental health Comprehensive Psychiatry 50 2009 181 185
93. R. Mojtabai, J. Lavelle, P.J. Gibson, N.L. Sohler, T.J. Craig, G.A. Carlson, and E.J. Bromet Gaps in use of antipsychotics after discharge by first-admission patients with schizophrenia, 1989 to 1996 Psychiatric Services 53 2002 337 339 (Pubitemid 34184688)
94. K.T. Mueser, W. Lu, S.D. Rosenberg, and R. Wolfe The trauma of psychosis: posttraumatic stress disorder and recent onset psychosis Schizophrenia Research 116 2010 217 227
95. B.P. Murphy, C. Simms, R.M. Dowling, A. Graham, A. Doherty, and G.N. Meadows The development of the recovery and prevention of psychosis service in Melbourne, Australia Early Intervention in Psychiatry 3 2009 151 156
96. S.H. Mutsatsa, E.M. Joyce, S.B. Hutton, E. Webb, H. Gibbins, S. Paul, and T.R. Barnes Clinical correlates of early medication adherence: West London first episode schizophrenia study Acta Psychiatrica Scandinavica 108 2003 439 446 (Pubitemid 37452828)
97. H.A. Nasrallah, S.D. Targum, R. Tandon, J.S. McCombs, and R. Ross Defining and measuring clinical effectiveness in the treatment of schizophrenia Psychiatric Services 56 2005 273 282 (Pubitemid 40333559)
98. J.W. Newcomer Metabolic considerations in the use of antipsychotic medications: a review of recent evidence The Journal of Clinical Psychiatry 68 Suppl. 1 2007 20 27
99. R.M. Norman, and A.K. Malla Duration of untreated psychosis: a critical examination of the concept and its importance Psychological Medicine 31 2001 381 400 (Pubitemid 32294037)
100. R.M. Norman, A.K. Malla, M.B. Verdi, L.D. Hassall, and C. Fazekas Understanding delay in treatment for first-episode psychosis Psychological Medicine 34 2004 255 266 (Pubitemid 38239633)
101. M. Nosé, C. Barbui, and M. Tansella How often do patients with psychosis fail to adhere to treatment programmes? A systematic review Psychological Medicine 33 2003 1149 1160 (Pubitemid 37265204)
102. V. Novak-Grubic, and R. Tavcar Predictors of noncompliance in males with first-episode schizophrenia, schizophreniform and schizoaffective disorder European Psychiatry 17 2002 148 154 (Pubitemid 34800021)
103. D. Novick, J.M. Haro, D. Suarez, V. Perez, R.W. Dittmann, and P.M. Haddad Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia Psychiatric Research 176 2010 109 113
104. C. O'Donnell, G. Donohoe, L. Sharkey, N. Owens, M. Migone, R. Harries, A. Kinsella, C. Larkin, and E. O'Callaghan Compliance therapy: a randomised controlled trial in schizophrenia BMJ 327 2003 834
105. J. Onwumere, P. Bebbington, and E. Kuipers Family interventions in early psychosis: specificity and effectiveness Epidemiology and Psychiatric Science 20 2011 113 119
106. M. Parellada, L. Boada, D. Fraguas, S. Reig, J. Castro-Fornieles, D. Moreno, A. Gonzalez-Pinto, S. Otero, M. Rapado-Castro, M. Graell, I. Baeza, and C. Arango Trait and state attributes of insight in first episodes of early-onset schizophrenia and other psychoses: a 2-year longitudinal study Schizophrenia Bulletin 37 2011 38 51
107. V. Patel, A.J. Flisher, S. Hetrick, and P. McGorry Mental health of young people: a global public-health challenge Lancet 369 2007 1302 1313 (Pubitemid 46552025)
108. J. Payne, A. Malla, R. Norman, D. Windell, and B. Nicole Status of first-episode psychosis patients presenting for routine care in a defined catchment area Canadian Journal of Psychiatry 51 2006 42 47 (Pubitemid 43234945)
109. A. Pencer, J. Addington, and D. Addington Outcome of a first episode of psychosis in adolescence: a 2-year follow-up Psychiatric Practice 133 2005 35 43
110. D.O. Perkins Predictors of noncompliance in patients with schizophrenia The Journal of Clinical Psychiatry 63 2002 1121 1128 (Pubitemid 36084056)
111. D. Perkins, J. Lieberman, H. Gu, M. Tohen, J. McEvoy, A. Green, R. Zipursky, S. Strakowski, T. Sharma, R. Kahn, R. Gur, G. Tollefson HGDH Research Group Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders The British Journal of Psychiatry 185 2004 18 24 (Pubitemid 38951625)
112. D.O. Perkins, J.L. Johnson, R.M. Hamer, R.B. Zipursky, R.S. Keefe, F. Centorrhino, A.I. Green, I.B. Glick, R.S. Kahn, T. Sharma, M. Tohen, J.P. McEvoy, P.J. Weiden, J.A. Lieberman HGDH Research Group Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode Schizophrenia Research 83 2006 53 63
113. D.O. Perkins, H. Gu, P.J. Weiden, J.P. McEvoy, R.M. Hamer, J.A. Lieberman Comparison of Atypicals in First Episode Study Group Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study The Journal of Clinical Psychiatry 69 2008 106 113 (Pubitemid 351282003)
114. L. Petersen, P. Jeppesen, A. Thorup, M.B. Abel, J. Ehlenschlaeger, T.E. Christensen, G. Krarup, P. Jørgensen, and M. Nordentoft A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness BMJ 331 2005 602
115. F. Pharoah, J. Mari, J. Rathbone, and W. Wong Family intervention for schizophrenia Cochrane Database of Systematic Reviews 12 2010 CD000088
116. M. Rabinovitch, L. Béchard-Evans, N. Schmitz, R. Joober, and A. Malla Early predictors of nonadherence to antipsychotic therapy in first-episode psychosis Canadian Journal of Psychiatry 54 2009 28 35
117. C. Redmond, M. Larkin, and C. Harrop The personal meaning of romantic relationships for young people with psychosis Clinical Child Psychology and Psychiatry 15 2010 151 170
118. A.R. Riana, C.B. Osman, and O. Ainsah Psychiatric morbidity and attitudes towards mental illness among patients attending primary care clinic of Hospital Universiti Kebangsaan Malaysia Malaysian Journal of Psychiatry 17 2008 1 14
119. D. Robinson, M.G. Woerner, J.M. Alvir, R. Bilder, R. Goldman, S. Geisler, A. Koreen, B. Sheitman, M. Chakos, D. Mayerhoff, and J.A. Lieberman Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder Archives of General Psychiatry 56 1999 241 247 (Pubitemid 29125132)
120. D.G. Robinson, M.G. Woerner, J.M. Alvir, R.M. Bilder, G.A. Hinrichsen, and J.A. Lieberman Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder Schizophrenia Research 57 2002 209 219 (Pubitemid 35240023)
121. C. Rummel-Kluge, K. Komossa, S. Schwarz, H. Hunger, F. Schmid, W. Kissling, J.M. Davis, and S. Leucht Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons Schizophrenia Bulletin 2010 10.1093/schbul/sbq042
122. C. Rummel-Kluge, K. Komossa, S. Schwarz, H. Hunger, F. Schmid, C.A. Lobos, W. Kissling, J.M. Davis, and S. Leucht Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis Schizophrenia Research 123 2010 225 233
123. E. Saito, C.U. Correll, K. Gallelli, M. McMeniman, U.H. Parikh, A.K. Malhotra, and V. Kafantaris A prospective study of hyperprolactinemia in children and adolescents treated with atypical antipsychotic agents Journal of Child and Adolescent Psychopharmacology 14 2004 350 358 (Pubitemid 39473121)
124. B.G. Schimmelmann, C. Mehler-Wex, M. Lambert, C. Schulze-zur-Wiesch, E. Koch, H.H. Flechtner, B. Gierow, J. Maier, E. Meyer, and M. Schulte-Markwort A prospective 12-week study of quetiapine in adolescents with schizophrenia spectrum disorders Journal of Child and Adolescent Psychopharmacology 17 2007 768 778 (Pubitemid 351158602)
125. M.B. Short, and S.L. Rosenthal Psychosocial development and puberty Annals of the New York Academy of Sciences 1135 2008 36 42 (Pubitemid 351862126)
126. S.P. Singh, and T. Grange Measuring pathways to care in first-episode psychosis: a systematic review Schizophrenia Research 81 2006 75 82 (Pubitemid 41817208)
127. S.P. Singh, and C. Merino Treatment of first-episode and prodromal signs Psychiatry 7 2008 467 471
128. D. Srebnik, and J. Lafond Advance directives for mental health services: current perspectives and future directions Psychiatric Services 54 1999 981 986
129. K. Steger, C. Cassidy, M. Rabinovitch, R. Joober, and A. Malla Role of symptom remission in determining medication adherence in early psychosis Schizophrenia Bulletin 37 Suppl. 1 2011 1 327 10.1093/schbul/sbq173
130. E. Stip, A. Abdel-Baki, D. Bloom, S. Grignon, and M.A. Roy Les antipsychotiques injectables à action prolongée: avis d'experts de l'Association des médecins psychiatres du Québec Canadian Journal of Psychiatry 56 2011 367 376
131. S. Stübner, R. Grohmann, R. Engel, B. Bandelow, W.D. Ludwig, G. Wagner, B. Müller-Oerlinghausen, H.J. Möller, H. Hippius, and E. Rüther Blood dyscrasias induced by psychotropic drugs Pharmacopsychiatry 37 Suppl. 1 2004 S70 S78
132. J. Swanson, M.S. Swartz, E.B. Elbogen, R.A. Van Dorn, H.R. Wagner, L.A. Moser, C. Wilder, and A.R. Gilbert Psychiatric advance directives and reduction of coercive crisis interventions Journal of Mental Health 17 2008 255 267 (Pubitemid 351896716)
133. L. Tennakoon, D. Fannon, V. Doku, S. O'Ceallaigh, W. Soni, M. Santamaria, E. Kuipers, and T. Sharma Experience of caregiving: relatives of people experiencing a first episode of psychosis The British Journal of Psychiatry 177 2000 529 533 (Pubitemid 32005484)
134. M. Tohen, S.M. Strakowski, C. Zarate Jr., J. Hennen, A.L. Stoll, T. Suppes, G.L. Faedda, B.M. Cohen, P. Gebre-Medhin, and R.J. Baldessarini The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis Biological Psychiatry 48 2000 467 476
135. P. Toren, S. Ratner, N. Laor, and A. Weizman Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents Drug Safety 27 2004 1135 1156 (Pubitemid 39647854)
136. P. Tucker Substance misuse and early psychosis Australasian Psychiatry 17 2009 291 294
137. S.L. Tunis, D.E. Faries, M.D. Stensland, D.P. Hay, and B.J. Kinon An examination of factors affecting persistence with initial antipsychotic treatment in patients with schizophrenia Current Medical Research and Opinion 23 2007 97 104 (Pubitemid 46191675)
138. A. Turkington, C.C. Mulholland, T.M. Rushe, R. Anderson, R. McCaul, S.L. Barrett, R.S. Barr, and S.J. Cooper Impact of persistent substance misuse on 1-year outcome in first-episode psychosis The British Journal of Psychiatry 195 2009 242 248
139. J.N. van den Anker Developmental pharmacology Developmental Disabilities Research Reviews 16 2010 233 238
140. D.I. Velligan, P.J. Weiden, M. Sajatovic, J. Scott, D. Carpenter, R. Ross, and J.P. Docherty The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness The Journal of Clinical Psychiatry 70 Suppl. 4 2009 1 46
141. H. Verdoux, J. Lengronne, F. Liraud, B. Gonzales, F. Assens, F. Abalan, and J. van Os Medication adherence in psychosis: predictors and impact on outcome. A 2-year follow-up of first-admitted subjects Acta Psychiatrica Scandinavica 102 2000 203 210 (Pubitemid 30663329)
142. B. Vitiello, C. Correll, B. van Zwieten-Boot, A. Zuddas, M. Parellada, and C. Arango Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns European Neuropsychopharmacology 19 2009 629 635
143. P.J. Weiden, J.A. Mackell, and D.D. McDonnell Obesity as a risk factor for antipsychotic noncompliance Schizophrenia Research 66 2004 51 57 (Pubitemid 38030344)
144. K.A. Weiss, T.E. Smith, J.W. Hull, A.C. Piper, and J.D. Huppert Predictors of risk of nonadherence in outpatients with schizophrenia and other psychotic disorders Schizophrenia Bulletin 28 2002 341 349 (Pubitemid 35462249)
145. J.S. Werry, J.M. McClellan, L.K. Andrews, and M. Ham Clinical features and outcome of child and adolescent schizophrenia Schizophrenia Bulletin 20 1994 619 630 (Pubitemid 24373734)
146. D. Whitehorn, J. Brown, J. Richard, Q. Rui, and L. Kopala Multiple dimensions of recovery in early psychosis International Review of Psychiatry 14 2002 273 283 (Pubitemid 35398853)
147. B.D. Wiffen, J. Rabinowitz, A. Lex, and A.S. David Correlates, change and 'state or trait' properties of insight in schizophrenia Schizophrenia Research 122 2010 94 103
148. L. Wunderink, F.J. Nienhuis, S. Sytema, C.J. Slooff, R. Knegtering, and D. Wiersma Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome The Journal of Clinical Psychiatry 68 2007 654 661 (Pubitemid 46841847)
149. L. Wunderink, S. Sytema, F.J. Nienhuis, and D. Wiersma Clinical recovery in first-episode psychosis Schizophrenia Bulletin 35 2009 362 369
150. H.L. Yap Early psychosis intervention Singapore Medical Journal 51 2010 689 693